Nectar Lifesciences has informed that a meeting of the Board of Directors of the Company will be held on May 28, 2018, to consider and approve the Audited Financial Results for the Financial Year 2017-18, Financial Statements of the Company for the Financial Year 2017-18 and matters related thereto; and recommendation of final dividend to the Members of the Company for Financial Year 2017-18. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window of the Company shall stand closed from May 21, 2018 to May 30, 2018.
The above information is a part of company’s filings submitted to BSE.
